All News

Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestone

REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately [...]

2023-10-18T11:06:33+01:00October 18th, 2023|All News, Company News|

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that [...]

2024-02-27T15:24:34+00:00September 19th, 2023|All News, Company News|

Virtual Incision Extends Series C Round with Additional $30M Funding

Investment will accelerate advancements of the MIRA Surgical System LINCOLN, Neb. – September 19, 2023 – Virtual Incision Corporation, the developer of the world’s first miniaturized robotic-assisted surgery (RAS) system, today announced a $30 million extension to its previous $46 million Series C financing. The round was led by current investors [...]

2023-09-19T17:00:12+01:00September 19th, 2023|All News, Company News|

The MIRA Surgical System Proceeds to FDA Substantive Review for Market Authorization Under the De Novo Classification Pathway

Virtual Incision Has Achieved a Significant Milestone in Its De Novo Request and is Closer to Potential Commercial Readiness  Lincoln, Neb. – May 18, 2023 – Virtual Incision Corporation today announced its De Novo request was submitted and is under substantive review by the U.S. Food and Drug Administration (FDA). [...]

2023-11-20T12:16:48+00:00May 18th, 2023|All News, Company News|

Relievant Medsystems Announces More Than 10,000 Patients Treated with the Intracept® Procedure for Vertebrogenic Low Back Pain

MINNEAPOLIS, May 09, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, today announced that more than 10,000 patients have been treated with the Intracept® Procedure. This is the latest in a series of milestone accomplishments as the [...]

2023-05-10T08:04:11+01:00May 9th, 2023|All News, Company News|

Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain

MINNEAPOLIS, April 19, 2023 (GLOBE NEWSWIRE) --  Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that it has completed the close of its $50 million Series G financing. The financing was led by [...]

2023-06-21T08:54:25+01:00April 19th, 2023|All News, Company News|

Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization

REDWOOD CITY, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief Executive Officer of the company. Mr. [...]

2023-04-13T10:58:51+01:00April 13th, 2023|All News, Company News|

Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Basel, 17 March 2023: Medartis Holding AG (SIX: MED), an orthopaedic company specialising in head and extremity surgery, today announced the successful completion of a small capital increase of CHF 30 million in a private placement to finance an additional stake [...]

2023-05-02T10:31:51+01:00March 17th, 2023|All News, Company News|

Neurovascular technology Q&A with Endeavour Vision’s Investment Manager, Toby AuWerter

As an investor in healthcare technologies, we are always on the lookout for areas of unmet need where new technologies have the potential to improve patient outcomes. The neurovascular technology sector is one such field. Neurovascular conditions occur when an area of the brain is affected by restricted blood flow [...]

2023-03-28T14:18:15+01:00March 7th, 2023|All News, Blog, Medtech|
Go to Top